This topic contains a solution. Click here to go to the answer

Author Question: Describe the fundamental flaw that prevents a nonequivalent group design from being a true ... (Read 68 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
Describe the fundamental flaw that prevents a nonequivalent group design from being a true experiment. (That is, why can't these designs produce an unambiguous cause-and-effect explanation?) Explain how the pretest scores in a pretest-posttest nonequivalent control group design help reduce this problem.
 
  What will be an ideal response?

Question 2

What social threat to internal validity occurs when the control group is given a program or treatment (usually by a well-meaning third party) designed to make up for the treatment the program group receives?
 
  a. diffusion of treatment
 b. compensatory rivalry
 c. resentful demoralization
 d. compensatory equalization



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Brenm

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

The basic flaw with a nonequivalent group design is that there is no assurance that the different groups in the study were equivalent before the treatments were administered. As a result, there are always two possible explanations for any differences that may be found between treatments: the differences may be caused by the treatments or the differences may have existed before the treatments were introduced. This problem is reduced by the pretest measurements in a pretest-posttest nonequivalent control group design. If the two groups have similar pretest scores, then you have some assurance that the two groups are equivalent, at least for the variable being measured.

Answer to Question 2

d





 

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

For a complete list of videos, visit our video library